Zobrazeno 1 - 6
of 6
pro vyhledávání: '"A P, Mesniankin"'
Publikováno v:
Klinicheskaia laboratornaia diagnostika. (6)
The level of medium-weight molecules (MWM) over the course of disease and changes in the lipid share of MWM fractions at the peak of disease were studied in patients with Astrakhan rickettsial fever (ARF). The level of MWM was significantly increased
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::a11972f3632fad717aaa3be7ce2f25e7
https://pubmed.ncbi.nlm.nih.gov/10459205
https://pubmed.ncbi.nlm.nih.gov/10459205
Publikováno v:
Terapevticheskii arkhiv. 68(4)
Clinicomorphological characteristics are given of primary reaction at the site of tick (Rhipicephalus pumilio) bite in new rickettsiosis spreading in Astrakhan Province--Astrakhan fever. The disease presented with long-term fever (body temperature 39
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::9ce3033b354e2bd48d6ee1f9e6a393bb
https://pubmed.ncbi.nlm.nih.gov/9324803
https://pubmed.ncbi.nlm.nih.gov/9324803
Autor:
Kh M, Galimzianov, N I, Rasskazov, S A, Altukhov, A P, Mesniankin, S S, Afanas'ev, L A, Denisov
Publikováno v:
Terapevticheskii arkhiv. 68(2)
Astrakhan fever is a new endemic rickettsiosis belonging to the group of tick-borne spotted fevers. Adjuvant use of interferons in basic treatment of Astrakhan fever elevates its efficacy. The maximal contribution of interferons can be reached at adm
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::cc947d3483ca97b06b45474fb4d1931d
https://pubmed.ncbi.nlm.nih.gov/8771664
https://pubmed.ncbi.nlm.nih.gov/8771664
Publikováno v:
Zhurnal mikrobiologii, epidemiologii i immunobiologii. (4)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::de702207e89c691c801f7cb49a23008a
https://pubmed.ncbi.nlm.nih.gov/2385996
https://pubmed.ncbi.nlm.nih.gov/2385996
Autor:
N D, Iushchuk, A V, Zmyzgova, I V, Tugutova, V P, Kuznetsov, A A, Babaiants, T A, Novikova, O F, Eremina, A P, Mesniankin, V V, Lebedev, M A, V'iushina
Publikováno v:
Sovetskaia meditsina. (7)
Tolerance and immunomodulating properties of leukinferon for injections were studied in 13 healthy volunteers. The drug was administered by inhalation and intramuscularly in a single dose of 10,000 MU twice daily for 3 days. Intramuscular injections
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::6238045f5871f5c980cf4388c00218b5
https://pubmed.ncbi.nlm.nih.gov/2251550
https://pubmed.ncbi.nlm.nih.gov/2251550
Autor:
V I, Pokrovskiĭ, A V, Zmyzgova, E Sh, Botsvadze, M A, Andreĭchin, V M, Frolov, R T, Murzabaeva, A P, Mesniankin, L N, Kokareva, V V, Malinovskaia
Publikováno v:
Terapevticheskii arkhiv. 62(2)
The clinical trials of alpha 2-interferon (alpha 2-IF) (reaferon) in 412 patients with acute viral hepatitis B (AVHB) permitted the establishment of the optimal therapeutic dose and the schedule for the drug use. The drug tolerance appeared satisfact
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::5a92113f83d21d2cb820cb6b8cffb7e1
https://pubmed.ncbi.nlm.nih.gov/2186494
https://pubmed.ncbi.nlm.nih.gov/2186494